Pathophysiology of COVID-19-associated acute kidney injury

M Legrand, S Bell, L Forni, M Joannidis… - Nature Reviews …, 2021 - nature.com
Although respiratory failure and hypoxaemia are the main manifestations of COVID-19,
kidney involvement is also common. Available evidence supports a number of potential …

The COVID-19 puzzle: deciphering pathophysiology and phenotypes of a new disease entity

MF Osuchowski, MS Winkler, T Skirecki… - The Lancet …, 2021 - thelancet.com
The zoonotic SARS-CoV-2 virus that causes COVID-19 continues to spread worldwide, with
devastating consequences. While the medical community has gained insight into the …

Long-term lung abnormalities associated with COVID-19 pneumonia

JP Kanne, BP Little, JJ Schulte, A Haramati… - Radiology, 2022 - pubs.rsna.org
In the 3rd year of the SARS-CoV-2 pandemic, much has been learned about the long-term
effects of COVID-19 pneumonia on the lungs. Approximately one-third of patients with …

Endothelial dysfunction in acute and long standing COVID− 19: A prospective cohort study

E Oikonomou, N Souvaliotis, S Lampsas, G Siasos… - Vascular …, 2022 - Elsevier
Abstract Background Coronavirus disease-19 (COVID-19) is implicated by active
endotheliitis, and cardiovascular morbidity. The long-COVID-19 syndrome implications in …

Invited Review: The spectrum of neuropathology in COVID‐19

S Al‐Sarraj, C Troakes, B Hanley… - Neuropathology and …, 2021 - Wiley Online Library
There is increasing evidence that patients with Coronavirus disease 19 (COVID‐19) present
with neurological and psychiatric symptoms. Anosmia, hypogeusia, headache, nausea and …

Face mask—A potential source of phthalate exposure for human

H Xie, W Han, Q Xie, T Xu, M Zhu, J Chen - Journal of hazardous materials, 2022 - Elsevier
Face masks are necessary for fighting against the coronavirus disease 2019 around the
world. As the face mask is usually made from polymers and phthalates are widely-used …

SARS-CoV-2/COVID-19 and advances in developing potential therapeutics and vaccines to counter this emerging pandemic

AA Rabaan, SH Al-Ahmed, R Sah, R Tiwari… - Annals of Clinical …, 2020 - Springer
A novel coronavirus (SARS-CoV-2), causing an emerging coronavirus disease (COVID-19),
first detected in Wuhan City, Hubei Province, China, which has taken a catastrophic turn with …

COVID-19 associated mucormycosis: the urgent need to reconsider the indiscriminate use of immunosuppressive drugs

AJ Rodriguez-Morales, R Sah… - Therapeutic …, 2021 - journals.sagepub.com
Therapeutic Advances in Infectious Disease 8 2 journals. sagepub. com/home/tai caring for
patients with COVID-19, the empiric overuse of corticosteroids has been associated with …

Why is COVID-19 more severe in patients with diabetes? The role of angiotensin-converting enzyme 2, endothelial dysfunction and the immunoinflammatory system

J Roberts, AL Pritchard, AT Treweeke… - Frontiers in …, 2021 - frontiersin.org
Meta-analyses have indicated that individuals with type 1 or type 2 diabetes are at increased
risk of suffering a severe form of COVID-19 and have a higher mortality rate than the non …

Kidney injury in COVID-19: epidemiology, molecular mechanisms and potential therapeutic targets

JP Teixeira, S Barone, K Zahedi… - International Journal of …, 2022 - mdpi.com
As of December 2021, SARS-CoV-2 had caused over 250 million infections and 5 million
deaths worldwide. Furthermore, despite the development of highly effective vaccines, novel …